{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:50:01Z","timestamp":1791330601286,"version":"4.3.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013494","name":"West Light Foundation, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22137008"],"award-info":[{"award-number":["22137008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473809"],"award-info":[{"award-number":["82473809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jare.2026.01.010","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:23:30Z","timestamp":1767659010000},"page":"1077-1093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Guaianolide dimer KGA-1002 targets GRP94 and triggers unfolded protein response-associated degradation of SKP2\/AKT axis as a novel antihepatoma agent"],"prefix":"10.1016","volume":"88","author":[{"given":"Qi-Hao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Cui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-5725","authenticated-orcid":false,"given":"Ji-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.01.010_b0005","unstructured":"Ferlay J et al. Global cancer observatory: cancer today. Lyon, France: innternational agency for research on cancer. available from: https:\/\/gco.iarc.who.int\/today (accessed 6 June 2025)."},{"key":"10.1016\/j.jare.2026.01.010_b0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2026.01.010_b0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2026.01.010_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Can Lett"},{"key":"10.1016\/j.jare.2026.01.010_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jare.2026.01.010_b0030","first-page":"e470","article-title":"Heat shock protein 90: biological functions, diseases, and therapeutic targets","volume":"2024","author":"Wei","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jare.2026.01.010_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.629846","article-title":"Molecular chaperone GRP94\/GP96 in cancers: oncogenesis and therapeutic target","volume":"11","author":"Duan","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2026.01.010_b0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc3701","article-title":"Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential","volume":"14","author":"Lee","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.01.010_b0045","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/med.21915","article-title":"The biology and inhibition of glucose-regulated protein 94\/gp96","volume":"42","author":"Pugh","year":"2022","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jare.2026.01.010_b0050","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1021\/ja303477g","article-title":"Development of a Grp94 inhibitor","volume":"134","author":"Duerfeldt","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jare.2026.01.010_b0055","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1007\/s13277-015-4254-9","article-title":"Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma","volume":"37","author":"Huang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0060","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1021\/pr0502469","article-title":"A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells","volume":"5","author":"Barati","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jare.2026.01.010_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154133","article-title":"Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94","volume":"101","author":"Cheng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2026.01.010_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ncb0409-377","article-title":"Skp2: caught in the Akt","volume":"11","author":"Ecker","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncb1849","article-title":"Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt\/PKB","volume":"11","author":"Lin","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0080","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/ddr.22087","article-title":"Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma","volume":"84","author":"Yan","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jare.2026.01.010_b0085","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1002\/anie.200200553","article-title":"Natural product hybrids as new leads for drug discovery","volume":"42","author":"Tietze","year":"2003","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jare.2026.01.010_b0090","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.apsb.2020.12.006","article-title":"New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity","volume":"11","author":"Su","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2026.01.010_b0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-022-01267-6","article-title":"Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT\/STAT signaling pathway","volume":"8","author":"He","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.01.010_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2024.114100","article-title":"Artemyriantholides A-K, guaiane-type sesquiterpenoid dimers from Artemisia myriantha var. pleiocephala and their antihepatoma activity","volume":"222","author":"Wang","year":"2024","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jare.2026.01.010_b0105","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1021\/acs.orglett.1c03120","article-title":"Biomimetic synthesis of lavandiolides H, I, and K and artematrolide F via Diels-Alder reaction","volume":"23","author":"Li","year":"2021","journal-title":"Org Lett"},{"key":"10.1016\/j.jare.2026.01.010_b0110","unstructured":"Chen J-J, Li T-Z, Ma Y-B, Geng C-A, Huang X-Y, Hu J, Zhang X-M, Guaiane sesquiterpene dimer and derivative thereof and application of guaiane sesquiterpene dimer and derivative thereof in pharmacy. Patent Number: CN115010719A. Application Date: Apr. 11, 2022."},{"key":"10.1016\/j.jare.2026.01.010_b0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","article-title":"Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer","volume":"68","author":"Li","year":"2025","journal-title":"J Adv Res"},{"issue":"4","key":"10.1016\/j.jare.2026.01.010_b0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/9780470559277.ch110180","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"3","author":"Lomenick","year":"2011","journal-title":"Curr Protoc Chem Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10637-021-01132-3","article-title":"Trilostane, a 3\u03b2-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib","volume":"39","author":"Lin","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jare.2026.01.010_b0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jare.2026.01.010_b0135","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.01.010_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-020-00447-6","article-title":"Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity","volume":"6","author":"Zeng","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.01.010_b0145","doi-asserted-by":"crossref","first-page":"E5986","DOI":"10.1073\/pnas.1706778114","article-title":"Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy","volume":"114","author":"Liao","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.01.010_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101362","article-title":"A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein","volume":"297","author":"Littler","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.01.010_b0155","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/jcp.24923","article-title":"Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis","volume":"230","author":"Zhu","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jare.2026.01.010_b0160","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.apsb.2020.11.015","article-title":"The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition","volume":"11","author":"Serwetnyk","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2026.01.010_b0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semcdb.2010.03.004","article-title":"GRP94 in ER quality control and stress responses","volume":"21","author":"Eletto","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.tem.2016.06.002","article-title":"Anticipatory UPR activation: a protective pathway and target in cancer","volume":"27","author":"Shapiro","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jare.2026.01.010_b0175","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajpath.2020.01.010","article-title":"Endoplasmic reticulum stress signaling in cancer cells","volume":"190","author":"Oakes","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2026.01.010_b0180","article-title":"Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2026.01.010_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021566","article-title":"Endoplasmic reticulum stress and cancer: could unfolded protein response be a druggable target for cancer therapy?","volume":"24","author":"Bonsignore","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jare.2026.01.010_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12964-022-00964-7","article-title":"Endoplasmic reticulum stress targeted therapy for breast cancer","volume":"20","author":"Xu","year":"2022","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jare.2026.01.010_b0195","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1101\/gad.238246.114","article-title":"Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis","volume":"28","author":"Wu","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.jare.2026.01.010_b0200","first-page":"44","article-title":"Downregulation of XBP1 protects kidney against ischemia-reperfusion injury via suppressing HRD1-mediated NRF2 ubiquitylation","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jare.2026.01.010_b0205","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.7150\/ijbs.33790","article-title":"PERK\/eIF-2\u03b1\/CHOP pathway dependent ROS generation mediates butein-induced non-small-cell lung cancer apoptosis and G2\/M phase arrest","volume":"15","author":"Di","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2026.01.010_b0210","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1101\/gad.1250704","article-title":"CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum","volume":"18","author":"Marciniak","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.jare.2026.01.010_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105218","article-title":"Endoplasmic reticulum stress and protein degradation in chronic liver disease","volume":"161","author":"Xia","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2026.01.010_b0220","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tibs.2018.06.005","article-title":"Quality control in the endoplasmic reticulum: crosstalk between ERAD and UPR pathways","volume":"43","author":"Hwang","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jare.2026.01.010_b0225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrd4432","article-title":"SCF ubiquitin ligase-targeted therapies","volume":"13","author":"Skaar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jare.2026.01.010_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jgg.2013.02.001","article-title":"Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer","volume":"40","author":"Xie","year":"2013","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.jare.2026.01.010_b0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2016.05.027","article-title":"Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery","volume":"111","author":"Hussain","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2026.01.010_b0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","article-title":"The Skp2 pathway: a critical target for cancer therapy","volume":"67","author":"Cai","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0245","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.95.19.11324","article-title":"Human CUL-1 associates with the SKP1\/SKP2 complex and regulates p21(CIP1\/WAF1) and cyclin D proteins","volume":"95","author":"Yu","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.01.010_b0250","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/s41467-021-27124-8","article-title":"The NUCKS1-SKP2-p21\/p27 axis controls S phase entry","volume":"12","author":"Hume","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.01.010_b0255","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.M301774200","article-title":"Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase","volume":"278","author":"Bornstein","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.01.010_b0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35060032","article-title":"Cytoplasmic localization of p21Cip1\/WAF1 by Akt-induced phosphorylation in HER-2\/neu-overexpressing cells","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0265","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","article-title":"The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis","volume":"149","author":"Chan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.01.010_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216848","article-title":"FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2","volume":"591","author":"Zheng","year":"2024","journal-title":"Can Lett"},{"key":"10.1016\/j.jare.2026.01.010_b0275","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ncb1847","article-title":"Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction","volume":"11","author":"Gao","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0280","first-page":"79","article-title":"ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Can"},{"key":"10.1016\/j.jare.2026.01.010_b0285","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","article-title":"GOT2 Silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"Can Res"},{"key":"10.1016\/j.jare.2026.01.010_b0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2024.05.045","article-title":"BCAT1 alleviates early brain injury by inhibiting ferroptosis through PI3K\/AKT\/mTOR\/GPX4 pathway after subarachnoid hemorrhage","volume":"222","author":"Liu","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2026.01.010_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.01.010_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155220","article-title":"Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT\/GSK3\u03b2\/NRF2\/GPX4 axis","volume":"123","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2026.01.010_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108654","article-title":"Akt \/ GSK3\u03b2 \/ Nrf2 \/ HO-1 pathway activation by flurbiprofen protects the hippocampal neurons in a rat model of glutamate excitotoxicity","volume":"196","author":"Farhat","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jare.2026.01.010_b0310","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI(3)K\/Akt-driven breast cancer","volume":"18","author":"Lien","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.01.010_b0315","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2026.01.010_b0320","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.freeradbiomed.2011.12.019","article-title":"Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence","volume":"52","author":"Dejeans","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2026.01.010_b0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41420-024-01956-x","article-title":"CK2\u03b1-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer","volume":"10","author":"Kim","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jare.2026.01.010_b0330","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1158\/1078-0432.CCR-13-2083","article-title":"Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma","volume":"19","author":"Hua","year":"2013","journal-title":"Clin Can Res"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322600010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322600010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:54:23Z","timestamp":1791327263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209012322600010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S209012322600010X"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.01.010","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guaianolide dimer KGA-1002 targets GRP94 and triggers unfolded protein response-associated degradation of SKP2\/AKT axis as a novel antihepatoma agent","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}